Should We Be Concerned About Vaccines Made in China?
The past few weeks, there have been a series of news reports coming out of China revealing that thousands of doses of improperly stored and expired vaccines for children and adults were illegally sold for millions of dollars on the black market by more than 100 people associated with…
GSK Business Strategy Based on Selling Lots of Vaccines
In its latest effort to increase its sales volume for vaccines and other pharmaceutical products, GlaxoSmithKline (GSK) of Great Britain has officially launched GSKDirect, described as a new “e-commerce platform that simplifies the way customers order vaccines and pharmaceutical…
Merck Leads World’s Top Vaccine Makers, Novartis Out
The vaccine manufacturing industry has long been dominated by five companies. In alphabetical order, these include multi-national firms GlaxoSmithKline plc (GSK) of Brentford, England; Merck & Co. of Kenilworth, NJ.; Novartis AG of Basel, Switzerland; Pfizer, Inc. of New York City, NY; and Sanofi Pasteur SA of Lyon, France. In 2014, the value of the world market for…
Pfizer Vaccines: From Cradle to Grave
The Associated Press (AP) is reporting that Pfizer, Inc. of New York has been significantly expanding its vaccines product line. In a press briefing on July 21, 2015, Pfizer officials expressed their company’s plans to have vaccines to help protect people “from cradle to grave, from shots for pregnant women to protect their babies from the moment of birth to vaccines…
Tufts University Study Pegs World Vaccine Sales at $40 Billion by 2020
The value of the world market for vaccines was estimated at $33.1 billion in 2014—up from $24 billion in 2009 and $5 billion in 2000. A new study conducted by Tufts University’s Center for the Study of Drug Development (CSDD) in Boston, MA forecasts annual sales of vaccines around the world will reach $40 billion by 2020. According to a summary of the…
Pharmaceutical Companies Developing 270 New Vaccines
The share of biologic-based drugs in the global pharmaceutical market is rising, with more and more products, especially vaccines, emerging from research and development efforts. A driving factor in biologic sector growth is drug company confidence that bigger revenue will be realized from the push to market. As of February 7, 2013, there were 907…